TSX:EXEHealthcare
2 Valuation Signals For Extendicare (TSX:EXE) After Earnings And Dividend Update
Extendicare earnings and dividend update
Extendicare (TSX:EXE) is back in focus after reporting its second quarter and first half 2026 results on August 6, alongside confirming its monthly cash dividend for August.
The company reported second quarter sales of CA$611.04 million with net income of CA$30.85 million. For the first six months of 2026, sales were CA$1,076.26 million and net income was CA$71.58 million.
See our latest analysis for Extendicare.
Extendicare’s latest earnings and...